The status of the HLA-DNA and -DOB genes in the HLA class II region has remained unclear for several years. Weak mRNA transcripts from each locus can be detected in B cells and some other cell types, but the issues of whether proteins are generated and, if so, whether they acquire partner chains to form class II heterodimers have not been resolved. The products of the homologous murine genes pair with each other to form the H-2O heterodimer. We now report that the products of HLA-DNA and -DOB are expressed as a heterodimer in humans, HLA-DO. It is expressed in various class II-positive cells including dendritic cells. The heterodimer associates with invariant chain and has a relatively short half-life. Its subcellular distribution differs from HLA-DR such that it is not expressed at the cell surface although it is found in some DR-containing compartments, suggesting a role at the intracellular stage of class II function. In the thymus, subpopulations of cells in both cortex and medulla, including HLA-DR ⍣ and DR -cells, are HLA-DO ⍣ . Hassall's corpuscles, a medullary site of thymocyte death, are ringed by HLA-DO ⍣ epithelium. This unusual pattern of expression may suggest a specialized role for HLA-DO in the thymus.
Introduction
The HLA class II region encompasses genes encoding not mutant, RJ2.2.5, expresses residual DOB mRNA despite having lost expression of all other class II transcripts (3) . only classical antigen -presenting molecules but also proteins involved in related functions such as TAP1, TAP2, LMP2, However, both genes have an intact X-box, Y-box, W-box, CRE motif and TATA box. Despite conservation of generic LMP7 and HLA-DM (1) . HLA class II sequences thus encode proteins targeted to the endoplasmic reticulum, to the cytoclass II proximal 5Ј regulatory sequences, HLA-DOB and -DNA mRNA are detected in B cell lines at about 5-10% of plasm, to the endosomal pathway or to the cell surface. During the mid-1980s, efforts to isolate new HLA class II DR mRNA (2, 3) . The sequences of HLA-DP, -DQ and -DR are as similar to each other as they are to the respective genes led to the cloning of two cDNA sequences, HLA-DNA and -DOB. Weak mRNA transcripts were detected in various sequences of -DNA and -DOB. The evolutionary conservation of HLA-DNA and -DOB has been taken as evidence of a cell types including B cells, fibroblasts and T cells (2) (3) (4) (5) (6) . The two genes are distantly separated in the HLA region, significant functional role (1) . Furthermore, expression of mRNA has been detected in all of the species where it has straddling the TAP, LMP and DM genes. The question of whether HLA-DNA and -DOB are expressed and, if so, what been examined (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) . The products of the homologous genes in the mouse pair are their respective partner chains has not been resolved, although there has been characterization of an in vitro transto form a heterodimer which has been termed H-2O (12, 13) . It is expressed at the cell surface of mouse peripheral B cells lated product of the HLA-DNA gene (7) .
HLA-DNA is inducible by IFN-γ, while HLA-DO was believed and in thymic medulla on a subpopulation of H-2A -epithelium (14). We set out to determine whether HLA-DNA and -DOB not to be (3) , suggesting the products were unlikely to form a pair. However, subsequent work showed that HLA-DOB is are expressed and, if so, whether they form a heterodimer. We also examined their localization within the thymus since inducible by IFN-γ but that the mRNA has an unusually short half-life (6) . Further evidence of differential control comes little is known about human thymic HLA expression and how this may affect T cell repertoire development. The transcript from the observation that the CIITA (class II trans-activator) of the HLA-DNA locus was originally termed DZα; in the F(abЈ) 2 -anti-mouse Ig (Jackson ImmunoResearch, West Grove, PA), streptavidin-Texas Red (Vector, UK) and streptaviinterest of consistency we have referred to the product of this locus as DNα; by analogy to the mouse we refer to the DNα/ din-Cy5 (Cambridge BioScience, Cambridge, UK Amersham, UK)/ml for the times specified in the figure legends denaturing agarose gel, blotted onto nylon filters and probed at 37°C. Aliquots were then either immediately pelleted on with an HLA-DRβ cDNA probe, or full-length DOβ and DNα ice or washed, resuspended in RPMI 10 at 10 7 cells/ml and cDNA probes which were supplied by Dr J. Trowsdale (Imperchased for defined periods. ial Cancer Research Fund, London, UK).
Immunoprecipitation Cell and tissues
Cells were lysed in lysis buffer [50 mM Tris, pH 7.4 150 nM The B lymphoblastoid cell line, PGF, HLA class II null mutant NaCl, 1% NP-40, 5 mM EDTA, 10 µg/ml mix of pepstatin, cell line, RJ2.2.5 (15) , and HLA class II ϩ melanoma, DX3, leupeptin, aprotinin and chemostatin, 1 µg/ml phenylmethylwere all maintained by passage in RPMI 1640 medium with sulphonyl fluoride (Sigma)] and the nuclear material was 10% FCS (RPMI 10). RJ2.2.5 transfected with HLA-DR1 (R/ pelleted. The solubilized membrane fractions were pre-cle-R1H) or HLA-DQw5 (Q/Q1H) were maintained by passage in ared twice for 2 h with 100 µl of Protein A-Sepharose RPMI 10 with 1 mg/ml Hygromycin B (Calbiochem, UK). Fresh (Pharmacia). While the lysates were pre-clearing 10 µl of human dendritic cells (a gift of M. Londei, Kennedy Institute, purified mAb or 25 µl of purified antiserum was added to 25 London, UK) had been cultured in granulocyte macrophage µl of Protein A-Sepharose and mixed at 4°C for 4 h in 0.5 ml colony stimulating factor for 4 days, and were characterized of lysis buffer. To inhibit immunoprecipitation, specific or by up-regulation of CD1 and HLA class II and down-regulation irrelevant peptide was added at 10 mg/ml to the relevant antiof CD14.
peptide antiserum and added to 25 µl of Protein A-Sepharose Thymuses were obtained from normal per-operative human and mixed at 4°C overnight in 0.5 ml of lysis buffer. If Western paediatric subjects. Tissue was immediately embedded in blotting was to be performed, antibody covalently coupled to OCT compound and snap frozen in isopentane in liquid Protein A-Sepharose with dimethylpimelimidate (Sigma) was nitrogen. Blocks were stored at -70°C until cut at into 5 µm used for the immunoprecipitation (see above). Lysates were sections in a cryostat.
added to the washed Protein A-Sepharose-antibody and mixed at 4°C for 2 h. Then, 25 µl of sample buffer with or Antisera against HLA-DNα and HLA-DOβ and mAb without 5% 1 M dithiothreitol, as indicated in the figure Rabbit antisera were raised against keyhole limpet haemalegends, was added to the washed immunoprecipitates and cyanin (KLH)-conjugated peptides corresponding to the cytothe samples were heated to 95°C for 5 min before loading plasmic tails of HLA-DNα (single-letter amino acid code on to 12% SDS-PAGE gels. Gels were dried and exposed to MGTYVSSVPR) and HLA-DOβ (SRAVLLPQSC). Peptides were BioMax MR film (Kodak, Cambridge, UK) or blotted onto conjugated to KLH (Sigma, Poole, UK) with glutaraldehyde.
membranes. Rabbits were immunized with peptide conjugate in adjuvant and serum was tested for antibody titre and peptide specificity Cell surface protein biotinylation and immunoprecipitation by ELISA. Pre-immune and immune antisera were purified on a Protein G-Sepharose Cl-4B column (Pharmacia, St Albans, After biosynthetic labelling, intact cells were incubated with 2.5 mg N-hydroxysuccinimide-SS-biotin (Pierce and Warriner, UK) and these preparations were used in all experiments except Fig. 1 
Cell surface iodination
were initially characterized by comparative staining of a Blymphoblastoid cell line, PGF, and the class II null mutant, Cells (5ϫ10 7 ) were washed and resuspended in 0.5 ml PBS. RJ2.2.5. It has previously been shown that HLA-DOβ tranThen, 50 µl lactoperoxidase (Sigma; diluted 1:10 in PBS) and scripts are made by RJ2.2.5 cells (3); we found that whereas 0.5 mCi Na 125 I (Amersham) were added to the cells and PGF produces weak mRNA transcripts for both HLA-DNα gently mixed on ice. Then, 5 µl of 0.003% (1 mM) hydrogen and -DOβ, RJ2.2.5 produces no DNα transcript and little peroxide (1:10,000 dilution in PBS of 30% stock) was added DOβ mRNA (Fig. 1A) . Despite the marginal amount of DOβ and the mixture gently swirled on ice. At 1 min intervals a transcript, staining of stable β chain would not be predicted further 5 µl H 2 O 2 was added four times. Cells were washed in the absence of a partner α chain. Antiserum to DOβ stains three times thoroughly in PBS and lysed, and proteins were PGF but not RJ2.2.5 ( Fig. 1D and E). Staining of PGF cells immunprecipitated as above.
could be inhibited by pre-incubation of the antiserum with Western blotting specific peptide (data not shown). The antiserum does not PGF cells (5ϫ10 7 ) were lysed, immunoprecipitated and run stain RJ2.2.5 transfectant cells expressing a high level of on 12% SDS-PAGE gels as described above. Gels were HLA-DR or -DQ (17) (data not shown). electroblotted onto Immobilon P membranes (Millipore, HLA-DO antisera precipitate a heterodimer Bedford, MA) which were probed with the antibodies indicated in the figure legends. Membranes were incubated with the PGF cells were biosynthetically labelled with [ 35 S]methionine appropriate HRP-conjugated second layer antibody (Jackson (1 h pulse) and lysates immunoprecipitated with Protein GImmunoResearch) and visualized using enhanced chemiluaffinity purified anti-DNα, anti-DOβ or the mAb TAL 14.1 (antiminescence (Amersham).
DRβ) before separation on SDS-PAGE ( Fig. 2a) . TAL 14.1 precipitated the expected HLA-DR α chain and β chains from Cell staining PGF B cells (lane 4), while the pre-immune rabbit serum PGF or RJ2.2.5 cells were spun onto glass slides and airprecipitates no similar sized product (lane 1). Pre-bleed dried. They were fixed and permeabilized for 10 min in icesera from rabbits prior to immunization with DNα or DOβ cold acetone and incubated for 1 h with TAL 1B5 or unpurified cytoplasmic tail peptide had, like hyperimmune anti-DNα and anti-DNα or anti-DOβ antiserum at a dilution of 1:50 in Tris--DOβ antisera, been subjected to Protein G-affinity purificabuffered saline. Slides were washed in Tris-buffered saline tion. Both DNα (lanes 2 and 5) and DOβ (lanes 3 and 8) and incubated with the appropriate HRP-conjugated second antisera precipitated species of mol. wt of~33-35 and 30 layer antibody and developed with diaminobenzidine (Fast kDa. The α chain bands comprise species at different stages DAB; Sigma). of glycosylation, due to the long pulse time of 1 h, and are therefore less discrete than the β chains which only possess Confocal fluorescence immunocytochemistry a single glycosylation site. Five-fold less TAL 14.1 immuno-DX3 cells were grown on glass slides, fixed and permeabilized precipitate was loaded on to the SDS-PAGE gel than in ice-cold methanol, and incubated for 1 h with FITCanti-DNα or anti-DOβ immunoprecipitate to prevent relative conjugated anti-CD74, anti-DNα and biotinylated L243 in over-exposure in the HLA-DR track. TBS. Slides were washed in TBS and incubated with LRSCTo control for specificity of the antisera, anti-DNα and anticonjugated mouse-adsorbed F(abЈ) 2 -anti-rabbit Ig and strep-DOβ were pre-incubated overnight with 10 mg/ml of specific tavidin-Cy5 for 30 min in TBS containing 1% mouse serum.
cytoplasmic tail peptide (anti-DNα with DNα peptide and antiStained cells were imaged immediately by confocal micro-DOβ with DOβ peptide). As a negative control samples were scopy (Leica, Heidlberg, Germany). DC were dried onto glass also pre-incubated with the peptide sequence from the other slides, fixed in methanol, and incubated with anti-DNα and chain. Precipitation of the class II heterodimer by DNα antibiotinylated L243. Second layers were FITC-conjugated serum is abolished by preincubation with DNα peptide (lane mouse-adsorbed F(abЈ) 2 -anti-rabbit Ig and streptavidin-6) but not DOβ peptide (lane 7). Similarly, HLA class II Texas Red. Slides were visualized as above.
precipitation by anti-DOβ is abrogated by DOβ peptide (lane Immunohistochemistry of thymic sections 9) but not by DNα peptide (lane 10). Precipitation of the HLA-DO α and β chain products was thus specific, depending on Cryosections (5 µM) were fixed in acetone and incubated for the specific sequences in the cytoplasmic tails of the two 1 h with DNα or DOβ antiserum, washed in TBS, incubated molecules. with FITC-conjugated mouse-adsorbed F(abЈ) 2 -anti-rabbit Ig However, since it was possible that immunoprecipitation and then incubated with either biotinylated L243, unconjugresulted from cross-reactive recognition of the cytoplasmic ated MR6 or 4β containing 1% mouse serum. After washing, tails of classical class II molecules expressed by PGF, the sections were then incubated with either streptavidin-Texas antisera were tested for the ability to precipitate HLA class II Red or LRSC-conjugated rabbit-adsorbed F(abЈ) 2 -anti-mouse heterodimer from RJ2. 7) . Therefore the anti-DO antisera precipitate a heterodimer which is not present in the class II null mutant on probing with any antibody. These data confirm that the proteins precipitated by anti-DNα and anti-DOβ pair to form RJ2.2.5 and which is neither HLA-DR nor -DQ.
Sequential immunoprecipitation and Western blotting of a heterodimer with an apparent mol. wt of~33 and 30 kDa respectively, and that they do not associate with the α or β PGF lysate was conducted to confirm that the products of HLA-DNA and -DOB pair to form a heterodimer, and that they chains of HLA-DR or -DQ. do not associate with HLA-DR or -DQ chains (Fig. 2c) . PGF HLA-DO has a short half-life and associates with invariant lysate was immunoprecipitated with pre-immune serum, antichain DNα, anti-DOβ, TAL 14.1 (anti-DRβ) or L2 (anti-DQα), all covalently conjugated to Protein A-Sepharose beads. Proteins Figure 3 (a) shows [ 35 S]methionine biosynthetic labelling of PGF cells and immunoprecipitation of TAL 14.1 and anti-DNα were separated by non-reducing SDS-PAGE and Western blotted. Five-fold less TAL 14.1 and L2 immunoprecipitate in which proteins were chased for up to 8 h. HLA-DR α and β chains matured throughout the 8 h chase and as maturation was loaded on to the SDS-PAGE gel than anti-DNα or anti-DOβ immunoprecipitate. The membranes were probed with increased the ratio of HLA-DR to Ii increased as expected. HLA-DO was successfully precipitated at chase times up to pre-immune serum, anti-DNα, anti-DOβ, a mixture of TAL 14.1 (anti-DRβ) and TAL 1B5 (anti-DRα) or a mixture of L2 (anti-2 h and was apparently also associated with Ii chain, although the ratio of HLA-DO to Ii remained constant with time. No DQα) and Leu 10 (anti-DQβ). Immunoprecipitation with either anti-DNα or anti-DOβ produced a band at~33-35kDa when HLA-DO could be immunoprecipitated at chase time points of 5 h or greater. Thus the cytoplasmic tail epitope recognized probed with the anti-DNα antiserum. Immunoprecipitation with either anti-DNα or anti-DOβ produced a band at~30 kDa by the antiserum is either being degraded (i.e. the molecule is short lived) or it is being masked. when probed with the anti-DOβ antiserum. Protein immunoprecipitated with either anti-DNα or anti-DOβ produced no bands Western blotting was used to confirm that the species coprecipitating with HLA-DO and migrating at~33 kDa is Ii (Fig. when probed with either a mixture of TAL 14.1 and TAL 1B5, a mixture of L2 and Leu 10 or pre-immune serum. Protein 3b). PGF lysate was immunoprecipitated with pre-immune serum, purified mouse IgG, anti-DNα, TAL 1B5 (anti-DRα) or immunoprecipitated with TAL 14.1 or L2 was recognized by neither anti-DNα, anti-DOβ nor pre-immune serum but showed VICY1 (anti-Ii). The membranes were probed with VICY1 (antiIi). Lysate immuoprecipitated with anti-Ii and then probed with α and β bands when probed with a mixture of TAL 14.1 and the cell surface. This was investigated by immunoprecipitation from cell surface biotinylated, biosynthetically labelled PGF cells (Fig. 3c) . At a chase time of 2 h biotinylated HLA-DR could be immunoprecipitated from the cell surface (lane 3) but no precipitate could be detected with anti-DNα or -DOβ (lanes 1 and 2) . HLA-DO should be detectable under these conditions if present at the cell surface since the HLA-DO antisera show precipitation of DOα and β from total cell lysate (lanes 4 and 5) as does TAL 14.1 (anti-DRβ) of DR (lane 6). Since the amount of expressed HLA-DO protein is low compared to HLA-DR it is impossible to rule out that the sensitivity of the assay is too low to detect very small amounts of surface protein. However, the results do indicate that little if any HLA-DO is expressed at the cell surface. The possible lack of surface expression was confirmed by [ 125 I]lactoperoxidase cell surface labelling (Fig. 3d) .
Subcellular distribution of HLA-DO
Subcellular localization of HLA-DO was examined in the class II-expressing human melanoma cell line, DX3, since it is a large and adherent cell type allowing good morphological resolution. Confocal microscopy of these cells confirms that HLA-DO is intracellular and not at the cell surface (Fig 4a) . lanes 3 and 6) . There is little or no DOβ cells (Fig. 4b) . (12, 14) . This has led to speculation chains and mol. wt are indicated by arrows. about a possible novel role in immune function. The distribution of the human homologue is different. In human thymus DO is expressed by a minority of cells in both cortex and medulla (Fig. 5) : the DOβ antiserum co-localizes with subpopulations anti-Ii shows specific Ii products of 33 and 35 kDa (lane 7) as well as a non-specific Ig light chain signal picked up by of MR6 ϩ cortical epithelium (18) and 4β ϩ medullary epithelium (19) . DOβ and DNα antisera display identical patterns of the second layer and also detected in the mouse Ig and preimmune serum tracks (lanes 2 and 3) . The anti-Ii mAb detects staining. Co-localization with the anti-DRα mAb L243 reveals that the medullary DO ϩ cells include both DR ϩ and DRthe same 33 and 35 kDa products in lysate precipitated by anti-DOβ (lane 4). Lane 8 shows the converse experiment in subsets. The keratinized whorls of epithelium which constitute Hassall's corpuscles are negative for DR, but their boundaries which lysate immunoprecipitated by anti-Ii was probed with anti-DNα confirming the association between Ii and HLA-DO.
are demarcated by a ring of strongly DO ϩ cells. Transcriptional regulation of class II genes in Hassall's corpuscles is unusual The observation that HLA-DO has a short half-life and does not mature into an Ii-free form suggested that it may not reach in other regards since it is the only tissue so far described in limited as originally thought from the murine studies, does not extend to all class II antigen-presenting cell types. Like Discussion HLA-DM, it is likely to function in an earlier, intracellular stage of peptide processing or loading. Clues to the function of The HLA-DO heterodimer is closely related to the classical class II molecules, with the same potential glycosylation sites HLA-DO may be gained by comparison of sequence motifs in the β chain of class II heterodimers. One of the key and the same potential for disulphide bonding of cysteine residues (2, 3, 20) . The relative conservation of DO sequences sequences for the class II antigen-presenting molecules, HLA-DR, -DQ and -DP, is the CD4 binding site which comand genomic organisation in the species so far analysed in detail (rabbit, rat, sheep, marsupial, mouse and human) has prises residues 134-138 of the β2 domain (26). This sequence in DOβ contains five amino acid substitutions with respect to been regarded as evidence of a conserved functional role (1, (8) (9) (10) (11) (12) (13) contains a targeting sequence in its cytoplasmic tail, YTPL, which targets the molecule to the MHC class II compartments The promoter sequence of HLA-DOB differs slightly in sequence and organization from that of classical class II of the lysosomal pathway (29, 30) . This sequence conforms to the consensus tyrosine-based targeting motif (single-letter molecules (20), and it was initially suggested that DOβ was not inducible by IFN-γ (3), although this was later found amino acid code), YXXZ, where Z is preferably an hydrophobic residue. Many proteins which are targeted directly from the not to be the case for all cell types examined (6). These observations of differential regulation of HLA-DOB and -DNA trans-Golgi network or by rapid internalization from the plasma membrane to endosomes and lysosomes use this motif or were thought to rule out the possibility that their products could form an expressed heterodimer (3); however, the murine another motif based on the dipeptide LZ (for review see 31). Furthermore, it has been reported that targeting of the LgpA homologue H-2O is expressed as a heterodimer and yet H2Ob has an upstream promoter region remarkably similar to protein to lysosomes is dependant on the motif GYRHV present in its cytoplasmic tail and that the proximity of the that of HLA-DOB (21,25) and is not induced by IFN-γ in macrophages. The thymus appears to be an important site glycine residue to the plasma membrane enhances this targeting (32) . The cytoplasmic tail of HLA-DOβ is unusual in of HLA-DO expression and it may prove that other cytokines other than IFN-γ are of importance for the thymic regulation that it is considerably longer than those of the other class II molecules. Its full sequence is GYVRTQMSGNEVSRAVLof HLA class II expression.
In the present study a number of differences are seen from LPQSC, which contains two potential lysosomal targeting motifs, (G)YVRT and LL. Each of these motifs alone would be previous analysis of H-2O in the mouse (12, 14) . Whereas H-2O was detectable at the cell surface, HLA-DO is intracellular sufficient to target DOβ to lysosomes. It is noteworthy that Letourner and Klausner (33) showed that chimeric proteins and the human heterodimer is present in thymic cortex whilst the mouse homologue was not. Furthermore, the expression composed of the Tac antigen (IL-2 receptor α chain) and both the YQPL and LL lysosomal targeting motifs of the CD3 of either H-2A or H-2O on murine thymic medullary epithelial cells was mutually exclusive, while in human thymus, dual γ and δ chains respectively were targeted directly to the lysosomes from the trans-Golgi network without going through positive cells are observed. Furthermore, the medullary epithelium demarcating the edges of Hassall's corpuscles are the cell surface and were subject to rapid degradation. Taken together, the data indicate that HLA-DO, like HLAstrongly DO ϩ . The failure to detect strong staining around Hassall's corpuscles in the mouse is not surprising since DM, is likely to have a functional role at an intracellular stage of class II biosynthesis, targeting and peptide loading. The these bodies are small and difficult to detect in murine thymus. Without having conducted detailed studies of H-2O it is possibility that it may be directly targeted to the lysosomal compartment may reflect this function; however, lysosomal difficult to ascertain which of the discrepancies are species differences and which simply attributable to differences in targeting motifs may also account for its rapid degradation and this would suggest that the function of HLA-DO may sensitivity of detection.
The observation that the HLA-DO heterodimer is not found reside in a pre-lysosomal compartment such as the Golgi network or the endoplasmic reticulum. at the cell surface argues that it has a function other than conventional presentation of exogenous peptides to the TCR.
Any model of HLA-DO function must also account for the fact that its tissue distribution, while not as limited as originally What could be the function of a class II heterodimer which is very highly conserved, shows limited polymorphism, is thought from murine studies (12, 14) , does not extend to all class II antigen-presenting cell types. It is expressed by B restricted to the earlier part of the class II biosynthetic pathway 
